Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 984 entries
View as:

A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT05590377 Org: User:
Start: 01/26/23 End: 05/22/24 Due: 05/22/25

Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT02015780 Org: User:
Start: 12/31/13 End: 01/31/16 Due: 01/31/17

A Study on Administration Choices of Vedolizumab and Outcomes for Adults With Inflammatory Bowel Disease (IBD) (VARIETY - CROATIA AND SLOVENIA)

Phase: N/A Priority: Normal
NCT ID: NCT04885920 Org: User:
Start: 02/22/22 End: 03/12/24 Due: 03/12/25

A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet

Phase: N/A Priority: Normal
NCT ID: NCT05353985 Org: User:
Start: 06/30/22 End: 11/06/24 Due: 11/06/25

A Study of TAK-919 in Healthy Japanese Adults (COVID-19)

Phase: N/A Priority: Normal
NCT ID: NCT04677660 Org: User:
Start: 01/07/21 End: 02/22/22 Due: 02/22/23

A Study of Brentuximab Vedotin in Combination With Cyclophosphamide, Doxorubicin (Hydroxydaunorubicin), Prednisone (CHP) in Chinese Participants With CD30-Positive (CD30+) Peripheral T-Cell Lymphomas (PTCL)

Phase: N/A Priority: Normal
NCT ID: NCT05673785 Org: User:
Start: 02/10/23 End: 12/31/27 Due: 12/31/28

Phase 1b Study Investigating Safety & Immunogenicity of TDV Given Intradermally by Needle or Needle-Free PharmaJet Injector

Phase: N/A Priority: Normal
NCT ID: NCT01765426 Org: User:
Start: 02/15/13 End: 06/26/14 Due: 06/26/15

Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01163266 Org: User:
Start: 07/31/10 End: 01/31/12 Due: 01/31/13

Efficacy of Ramelteon on Insomnia Symptoms Associated With Jet Lag in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00492011 Org: User:
Start: 02/28/07 End: 08/31/07 Due: 08/31/08

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT06100289 Org: User:
Start: 01/22/25 End: 06/30/27 Due: 06/30/28

An [^11C]T-773 Positron Emission Tomography (PET) Study to Determine Phosphodiesterase10A Occupancy by TAK-063

Phase: N/A Priority: Normal
NCT ID: NCT02370602 Org: User:
Start: 10/31/13 End: 03/31/14 Due: 03/31/15

Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac Disease

Phase: N/A Priority: Normal
NCT ID: NCT03738475 Org: User:
Start: 11/11/18 End: 07/22/19 Due: 07/22/20

A Survey to Describe the Experience and Unmet Needs of Persons Living With Von Willebrand Disease (VWD) and Their Caregivers

Phase: N/A Priority: Normal
NCT ID: NCT05695560 Org: User:
Start: 02/24/23 End: 11/30/23 Due: 11/30/24

A Study to Assess Clinical Effectiveness and Safety of Vedolizumab Intravenous in Real World Clinical Practice in Ulcerative Colitis (UC) Korean Participants

Phase: N/A Priority: Normal
NCT ID: NCT03535649 Org: User:
Start: 08/17/17 End: 12/18/18 Due: 12/18/19

Efficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00325728 Org: User:
Start: 03/21/06 End: 08/20/07 Due: 08/20/08

Efficacy and Safety of TAK-583 in Subjects With Diabetic Peripheral Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT00760955 Org: User:
Start: 09/30/06 End: 02/29/08 Due: 02/28/09

A Pilot Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Needle Safety Device (PFS+NSD) in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03948581 Org: User:
Start: 02/21/18 End: 09/21/18 Due: 09/21/19

Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn

Phase: N/A Priority: Normal
NCT ID: NCT00255190 Org: User:
Start: 01/31/06 End: 06/30/08 Due: 06/30/09

A Study of TAK-954 to Treat Gastrointestinal Dysfunction in Adults After Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03827655 Org: User:
Start: 03/07/19 End: 05/27/22 Due: 05/27/23

A Study of Vedolizumab in Adult Participants With Moderate to Severe Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT05837897 Org: User:
Start: 06/16/23 End: 05/30/31 Due: 05/30/32

Determination of a Questionnaire After Treatment With Pantoprazole at Full Dose and Half Dose in Adult Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/UK-506)

Phase: N/A Priority: Normal
NCT ID: NCT00261339 Org: User:
Start: 08/31/05 End: - Due: -

A Study to Observe Vedolizumab and Anti-tumour Necrosis Factors (Anti-TNFs) Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn's Disease (CD) Participants

Phase: N/A Priority: Normal
NCT ID: NCT03710486 Org: User:
Start: 02/19/19 End: 02/21/22 Due: 02/21/23

TAK-935 Multiple Rising Dose Study in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02539134 Org: User:
Start: 09/30/15 End: 04/30/16 Due: 04/30/17

A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT04938427 Org: User:
Start: 11/08/21 End: 01/25/24 Due: 01/25/25

A Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years Old

Phase: N/A Priority: Normal
NCT ID: NCT02616302 Org: User:
Start: 02/20/23 End: 10/31/27 Due: 10/31/28